|Articles|August 3, 2015
ASCO Presses for Inclusion of Older Adults in Research
With more than 60 percent of cancers in the United States occurring in people age 65 and older, the evidence base for treating older adults is sparse.
Advertisement
ASCO recently presented a position statement “Improving the Evidence Base for Treating Older Adults with Cancer.” With more than 60 percent of cancers in the United States occurring in people age 65 and older, the evidence base for treating older adults is sparse because they are underrepresented in clinical trials and trials designed specifically for them are rare. Developed by ASCO’s Cancer Research Committee, the organization call for five over-arching recommendations:
- Use clinical trials to improve the evidence base for treating older adults.
- Leverage research designs and infrastructure to improve the evidence base for treating older adults.
- Increase Food and Drug Administration (FDA) authority to incentivize and require research on older adults with cancer.
- Increase clinicians’ recruitment of older adults with cancer into clinical trials.
- Utilize journal policies to incentivize researchers to consistently report on the age distribution and health risk profiles of research participants.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
How AI Can Help Physicians Identify Eligible Trials FasterSeptember 5th 2025
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
